Skip to main content
. 2019 Mar 11;8(3):338. doi: 10.3390/jcm8030338

Figure 2.

Figure 2

Figure 2

Other-cause of mortality (OCM) with or without androgen deprivation therapy (ADT) according to age. (a) OCMFS according to three ADT groups divided by duration (ADT naïve, ADT <2 years (2Y), and ADT ≥2 years (2Y)) in younger population. (b) OCMFS according to three ADT groups divided by duration in elderly population. (c) OCMFS according to three ADT groups divided by duration in high-risk group of younger population. (d) OCMFS according to three ADT groups divided by duration in the high-risk group of the elderly population. (e) OCMFS according to three ADT groups divided by the duration in the intermediate-risk group of the younger population. (f) OCMFS according to three ADT groups divided by the duration in the intermediate-risk group of the elderly population. (g) OCMFS according to three ADT groups divided by the duration in the low-risk group of the younger population. (h) OCMFS according to three ADT groups divided by the duration in the low-risk group of the elderly population. OCMFS = other-cause of mortality (OCM)-free survival rate.